The group’s principal activity is to harvest therapeutic human proteins from Lemna aquatic plant and species of flora through its LEX System and Plantibodies technologies. The group’s products include pipeline, controlled relief Alfa interferon and Alfa interferon. The group markets its products under the brand names Locteron(TM) and BLX-883. The group operates from the United States.
